Valerie Voon

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Emotional stimuli and motor conversion disorder
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1428, USA
    Brain 133:1526-36. 2010
  2. ncbi request reprint Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Neurol 64:212-6. 2007
  3. ncbi request reprint Medication-related impulse control and repetitive behaviors in Parkinson's disease
    Valerie Voon
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland 20892 1428, USA
    Curr Opin Neurol 20:484-92. 2007
  4. ncbi request reprint Medication-related impulse control and repetitive behaviors in Parkinson disease
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bldg 10, Room 5S213, Bethesda, MD 20892 1428, USA
    Arch Neurol 64:1089-96. 2007
  5. ncbi request reprint Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
    V Voon
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1428, USA
    Neurology 67:1254-7. 2006
  6. pmc A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892 1428, USA
    Brain 131:2720-8. 2008
  7. ncbi request reprint Deep brain stimulation: neuropsychological and neuropsychiatric issues
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, Toronto, Canada
    Mov Disord 21:S305-27. 2006
  8. ncbi request reprint Prospective prevalence of pathologic gambling and medication association in Parkinson disease
    V Voon
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1428, USA
    Neurology 66:1750-2. 2006
  9. ncbi request reprint Antidepressant treatment outcomes of psychogenic movement disorder
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, Toronto, Ontario, Canada
    J Clin Psychiatry 66:1529-34. 2005
  10. pmc Impulsive choice and response in dopamine agonist-related impulse control behaviors
    Valerie Voon
    National Institutes of Health, 10 Center Drive, Bldg 10 Rm 7D37, Bethesda, MD 20892 1428, USA
    Psychopharmacology (Berl) 207:645-59. 2010

Detail Information

Publications31

  1. pmc Emotional stimuli and motor conversion disorder
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1428, USA
    Brain 133:1526-36. 2010
    ..Greater functional connectivity of limbic regions influencing motor preparatory regions during states of arousal may underlie the pathophysiology of motor conversion symptoms...
  2. ncbi request reprint Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Neurol 64:212-6. 2007
    ..To evaluate factors associated with pathological gambling (PG) in Parkinson disease (PD)...
  3. ncbi request reprint Medication-related impulse control and repetitive behaviors in Parkinson's disease
    Valerie Voon
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland 20892 1428, USA
    Curr Opin Neurol 20:484-92. 2007
    ..In patients on dopamine agonists, these behaviors as a group are relatively common, can have potentially devastating psychosocial consequences and are commonly hidden...
  4. ncbi request reprint Medication-related impulse control and repetitive behaviors in Parkinson disease
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bldg 10, Room 5S213, Bethesda, MD 20892 1428, USA
    Arch Neurol 64:1089-96. 2007
    ..The study of these behaviors allows not only improved clinical management but also greater insight into a biologically mediated complex behavioral model...
  5. ncbi request reprint Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
    V Voon
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1428, USA
    Neurology 67:1254-7. 2006
    ..4%. Compulsive shopping was 0.7%. Combined with our pathologic gambling data, the lifetime prevalence of these behaviors was 6.1% and increases to 13.7% in patients on dopamine agonists...
  6. pmc A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
    Valerie Voon
    National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892 1428, USA
    Brain 131:2720-8. 2008
    ..Postoperative depression should be carefully assessed and treated. A multidisciplinary assessment and follow-up is recommended...
  7. ncbi request reprint Deep brain stimulation: neuropsychological and neuropsychiatric issues
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, Toronto, Canada
    Mov Disord 21:S305-27. 2006
    ..Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed...
  8. ncbi request reprint Prospective prevalence of pathologic gambling and medication association in Parkinson disease
    V Voon
    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1428, USA
    Neurology 66:1750-2. 2006
    ..4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist...
  9. ncbi request reprint Antidepressant treatment outcomes of psychogenic movement disorder
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, Toronto, Ontario, Canada
    J Clin Psychiatry 66:1529-34. 2005
    ..Psychogenic movement disorder (PMD) is a subtype of conversion disorder. We describe the outcomes of a series of PMD patients following antidepressant treatment...
  10. pmc Impulsive choice and response in dopamine agonist-related impulse control behaviors
    Valerie Voon
    National Institutes of Health, 10 Center Drive, Bldg 10 Rm 7D37, Bethesda, MD 20892 1428, USA
    Psychopharmacology (Berl) 207:645-59. 2010
    ..Dopaminergic medication-related impulse control disorders (ICDs) such as pathological gambling and compulsive shopping have been reported in Parkinson's disease (PD)...
  11. ncbi request reprint Deep brain stimulation: preoperative issues
    Anthony E Lang
    Department of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 21:S171-96. 2006
    ..It outlines answers to a series of questions developed to address all aspects of deep brain stimulation preoperative decision-making...
  12. ncbi request reprint Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulation
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, UHN, Toronto, Canada
    Adv Neurol 96:130-47. 2005
    ..The paucity of the literature underscores the need for well-designed studies on psychiatric issues investigating both pathophysiology and clinical outcomes...
  13. doi request reprint Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Ann Neurol 68:963-8. 2010
    ..Further research, including larger clinical trials, is needed to assess the role of amantadine in the development and treatment of ICDs in PD...
  14. pmc Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors
    Valerie Voon
    National Institutes of Health, Bethesda, MD 20892 1428, USA
    Neuron 65:135-42. 2010
    ..Thus, our findings are consistent with a model whereby a distorted estimation of the gain cue underpins a choice bias toward gains...
  15. pmc Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Mov Disord 24:1461-7. 2009
    ..A positive screen should be followed by a comprehensive, clinical interview to determine the range and severity of symptoms, as well as need for clinical management...
  16. ncbi request reprint Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease
    Naomi P Visanji
    Toronto Western Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 21:1879-91. 2006
    ..The response of different components of the psychotomimetic behavior suggested the involvement of both dopaminergic and nondopaminergic mechanisms in their expression...
  17. ncbi request reprint Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery
    Valerie Voon
    Department of Psychiatry, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada
    J Neurosurg 103:246-51. 2005
    ..In the present study, preoperative psychiatric symptoms were systematically assessed in patients with PD presenting for routine preoperative psychiatric assessment...
  18. ncbi request reprint Punding prevalence in Parkinson's disease
    Janis M Miyasaki
    Movement Disorders Centre, Toronto Western Hospital, University Health Network, Krembil Neuroscience Centre, University of Toronto, Toronto, Canada
    Mov Disord 22:1179-81. 2007
    ..4%) in contrast with previous reports of 14%. Despite the low incidence, this behavior is disruptive and should be carefully elicited by physicians caring for Parkinson's disease patients...
  19. doi request reprint Psychopathology and psychogenic movement disorders
    Sarah Kranick
    Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
    Mov Disord 26:1844-50. 2011
    ..A careful psychological assessment is indicated to optimize therapeutic modalities...
  20. ncbi request reprint Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease
    Valerie Voon
    University of Toronto, Toronto Western Hospital University Health Network, Ontario, Canada
    Clin Neuropharmacol 27:90-2. 2004
    ..Potential mechanisms implicated in the response of psychosis to antidepressants are discussed...
  21. doi request reprint Response inhibition in motor conversion disorder
    Valerie Voon
    Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
    Mov Disord 28:612-8. 2013
    ..Our results point toward potential differences between conversion disorder subgroups. © 2013 Movement Disorder Society...
  22. ncbi request reprint Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease
    Marc N Potenza
    Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, New Haven, CT 06519, USA
    Nat Clin Pract Neurol 3:664-72. 2007
    ....
  23. ncbi request reprint Deep brain stimulation for treatment-resistant depression
    Helen S Mayberg
    Rotman Research Institute at Baycrest Centre, and Departments of Psychiatry and Neurology, University of Toronto, Toronto, Ontario, M6A 2E1, Canada
    Neuron 45:651-60. 2005
    ....
  24. pmc Diagnosis and treatment of impulse control disorders in patients with movement disorders
    Tiago A Mestre
    Movement Disorders Centre and the Edmond J Safra Program in Parkinson s Disease, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada
    Ther Adv Neurol Disord 6:175-88. 2013
    ..Unfortunately, their use is only supported by case reports, small case series or open-label clinical studies. Prospective, controlled studies are warranted. Ongoing investigations include naltrexone and nicotine...
  25. doi request reprint Psychogenic movement disorders: past developments, current status, and future directions
    Anthony E Lang
    Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 26:1175-86. 2011
    ..Given the personal and societal impact of these problems, further advances in our understanding of their pathogenesis and the subsequent development of effective therapies are sorely needed...
  26. ncbi request reprint Antidepressants and psychosis in Parkinson disease: a case series
    Valerie Voon
    Int J Geriatr Psychiatry 22:601-4. 2007
  27. ncbi request reprint Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease
    Valerie Voon
    Mov Disord 19:367-70. 2004
  28. ncbi request reprint Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
    Claire Ardouin
    Departement de Neurologie, CHU Grenoble, INSERM U318, Universite Joseph Fourier, Grenoble, France
    Mov Disord 21:1941-6. 2006
    ....
  29. ncbi request reprint Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease
    Susan H Fox
    Arch Neurol 63:1343-4. 2006
  30. ncbi request reprint Deep brain stimulation: postoperative issues
    Gunther Deuschl
    Department of Neurology, Christian Albrechts Universitat Kiel, Kiel, Germany
    Mov Disord 21:S219-37. 2006
    ..The report has been endorsed by the Scientific Issues Committee of the Movement Disorder Society and the American Society of Stereotactic and Functional Neurosurgery...
  31. ncbi request reprint Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14620, USA
    Mov Disord 22:1061-8. 2007
    ..These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development...